Translating immunity into cancer therapy: new findings from the first conference of the European Society for Cancer Immunology and Immunotherapy, an ESMO-EIS held in Athens, 15-17 November 2007.
作者信息
Pawelec Graham, Perez Sonia
机构信息
Center for Medical Research, Tübingen, Germany.
出版信息
Cancer Immunol Immunother. 2008 Oct;57(10):1505-9. doi: 10.1007/s00262-008-0484-7. Epub 2008 Mar 1.
Abstract
摘要
相似文献
1
Translating immunity into cancer therapy: new findings from the first conference of the European Society for Cancer Immunology and Immunotherapy, an ESMO-EIS held in Athens, 15-17 November 2007.将免疫转化为癌症治疗：2007年11月15 - 17日于雅典举行的欧洲癌症免疫学会和免疫治疗学会（ESMO - EIS）首届会议的新发现。
Cancer Immunol Immunother. 2008 Oct;57(10):1505-9. doi: 10.1007/s00262-008-0484-7. Epub 2008 Mar 1.
2
4th Symposium on Advances in Cancer Immunology and Immunotherapy, November 29-December 1, 2018, Athens, Greece.第四届癌症免疫学与免疫治疗进展研讨会，2018年11月29日至12月1日，希腊雅典
Cancer Immunol Immunother. 2019 Aug;68(8):1391-1400. doi: 10.1007/s00262-019-02364-2. Epub 2019 Jul 15.
3
Sixth Immunotherapy of Cancer conference (ITOC): advances and perspectives-a meeting report.第六届癌症免疫治疗会议（ITOC）：进展与展望——会议报告。
J Immunother Cancer. 2020 Feb;8(1). doi: 10.1136/jitc-2019-000268.
4
1st International Conference on Human &Translational Immunology.第一届人类与转化免疫学年会
Nat Immunol. 2016 Dec 16;18(1):1-4. doi: 10.1038/ni.3635.
5
Translating Science into Survival: Report on the Inaugural International Cancer Immunotherapy Conference.将科学转化为生存之道：首届国际癌症免疫治疗会议报告。
Cancer Immunol Res. 2016 Jan;4(1):3-11. doi: 10.1158/2326-6066.cir-15-0279.
6
Translating Science into Survival: Report on the Fifth International Cancer Immunotherapy Conference.将科学转化为生存之道：第五届国际癌症免疫治疗会议报告。
Cancer Immunol Res. 2020 Jan;8(1):3-6. doi: 10.1158/2326-6066.CIR-19-0888.
7
Translating Science into Survival: Report on the Third International Cancer Immunotherapy Conference.将科学转化为生存：第三届国际癌症免疫治疗会议报告。
Cancer Immunol Res. 2018 Jan;6(1):10-13. doi: 10.1158/2326-6066.CIR-17-0656.
8
International Society for Cell and Gene Therapy of Cancer (ISCGT) annual meeting: conference overview and introduction to the symposium papers.国际癌症细胞与基因治疗协会（ISCGT）年会：会议综述及研讨会论文介绍
Cancer Immunol Immunother. 2006 Nov;55(11):1406-11. doi: 10.1007/s00262-006-0187-x. Epub 2006 Jun 17.
9
4th Summer School in Immuno-Oncology, July 1st-3rd, 2021, Athens, Greece.第四届免疫肿瘤学暑期学校，2021年7月1日至3日，希腊雅典。
Front Biosci (Landmark Ed). 2021 Nov 30;26(11):1373-1382. doi: 10.52586/5030.
10
First conference on cancer immunotherapy gets "explosion of interest".首届癌症免疫治疗会议引发“极大关注”。
BMJ. 2015 Sep 11;351:h4876. doi: 10.1136/bmj.h4876.
本文引用的文献
1
Progress in vaccination against cancer-7: report of the meeting in Stockholm, September 10-11, 2007.癌症疫苗接种进展-7：2007年9月10日至11日于斯德哥尔摩召开会议的报告
Cancer Immunol Immunother. 2008 Apr;57(4):593-9. doi: 10.1007/s00262-007-0420-2. Epub 2007 Nov 20.
2
Adaptive immunity maintains occult cancer in an equilibrium state.适应性免疫使隐匿性癌症维持在平衡状态。
Nature. 2007 Dec 6;450(7171):903-7. doi: 10.1038/nature06309. Epub 2007 Nov 18.
3
High-throughput proteomics using antibody microarrays: an update.使用抗体微阵列的高通量蛋白质组学：最新进展
Expert Rev Mol Diagn. 2007 Sep;7(5):673-86. doi: 10.1586/14737159.7.5.673.
4
In situ detection of antigen-specific T cells in cryo-sections using MHC class I tetramers after dendritic cell vaccination of melanoma patients.黑色素瘤患者进行树突状细胞疫苗接种后，使用MHC I类四聚体在冷冻切片中对抗原特异性T细胞进行原位检测。
Cancer Immunol Immunother. 2007 Oct;56(10):1667-76. doi: 10.1007/s00262-007-0304-5. Epub 2007 Apr 18.
5
Vaccination against the forkhead family transcription factor Foxp3 enhances tumor immunity.针对叉头框蛋白家族转录因子Foxp3进行疫苗接种可增强肿瘤免疫。
Cancer Res. 2007 Jan 1;67(1):371-80. doi: 10.1158/0008-5472.CAN-06-2903.
6
Activation, coactivation, and costimulation of resting human natural killer cells.静息人自然杀伤细胞的激活、共激活和共刺激
Immunol Rev. 2006 Dec;214:73-91. doi: 10.1111/j.1600-065X.2006.00457.x.
7
Prospects for cervical cancer prevention by human papillomavirus vaccination.人乳头瘤病毒疫苗预防宫颈癌的前景
Cancer Res. 2006 Nov 1;66(21):10229-32. doi: 10.1158/0008-5472.CAN-06-0630.
8
Vaccination with a HER2/neu peptide induces intra- and inter-antigenic epitope spreading in patients with early stage breast cancer.用HER2/neu肽进行疫苗接种可诱导早期乳腺癌患者体内和抗原间表位扩展。
Surgery. 2006 Mar;139(3):407-18. doi: 10.1016/j.surg.2005.06.059.
9
In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line.使用源自人MUTZ-3细胞系的同种异体树突状细胞对肿瘤特异性细胞毒性T淋巴细胞进行体外致敏。
Cancer Immunol Immunother. 2006 Dec;55(12):1480-90. doi: 10.1007/s00262-006-0142-x. Epub 2006 Feb 9.
10
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma.细胞毒性T淋巴细胞相关抗原4阻断在转移性黑色素瘤患者中诱导的癌症消退和自身免疫
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8372-7. doi: 10.1073/pnas.1533209100. Epub 2003 Jun 25.
Zotero 插件